Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check3 days agoChange DetectedThe page footer updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a small software/UI revision. The change does not modify study details or how information is presented to users.SummaryDifference0.2%

- Check10 days agoChange DetectedNo textual content changes were detected on the page. The core study details, eligibility criteria, and locations remain unchanged; observed differences are layout or UI adjustments.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing the previous v3.6.4. This indicates an internal version update to the page rather than a change to the study information presented.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's documentation.SummaryDifference0.1%

- Check45 days agoChange DetectedNo textual additions or deletions are present for this page in the provided data; the study record appears unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedNo textual changes were detected in the provided data. The page content remains as before.SummaryDifference0.1%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.